Literature DB >> 970334

Quinidine-induced ventricular flutter and fibrillation without digitalis therapy.

R W Koster, H J Wellens.   

Abstract

Three cases are described with documented ventricular flutter and fibrillation during quinidine medication without concomitant digitalis therapy. In all three patients the arrhythmia developed while they were receiving moderate doses of quinidine. Although no changes in QRS width were observed after administration of quinidine, there was marked prolongation of the Q-T interval. The mechanism of development of ventricular flutter and fibrillation in patients taking quinidine may be similar to that in patients with the Q-T prolongation syndrome.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 970334     DOI: 10.1016/0002-9149(76)90471-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

Review 1.  A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?

Authors:  F A Fish; D M Roden
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

2.  On the relationship among QT interval, atrial fibrillation, and torsade de pointes.

Authors:  Dan M Roden; Prince Kannankeril; Dawood Darbar
Journal:  Europace       Date:  2007-09       Impact factor: 5.214

Review 3.  The quinidine-digoxin interaction in perspective.

Authors:  B Fichtl; W Doering
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

4.  Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors:  J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

5.  Hyperventilation versus bicarbonate therapy for alkalinization in tricyclic antidepressant overdose.

Authors:  D A Nousaine
Journal:  West J Med       Date:  1981-08

6.  Electrocardiogram abnormalities induced by amsacrine.

Authors:  R B Weiss; D Moquin; J D Adams; J D Griffin; H Zimbler
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

7.  Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.

Authors:  Dawood Darbar; John Kimbrough; Asif Jawaid; Robert McCray; Marylyn D Ritchie; Dan M Roden
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

Review 8.  Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.

Authors:  S Y Kim; N L Benowitz
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 9.  Drug-induced torsade de pointes. Incidence, management and prevention.

Authors:  T S Faber; M Zehender; H Just
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

10.  Torsades de pointes, a common arrhythmia, induced by medication.

Authors:  P T Ko; S Gulamhusein; W J Kostuk; G J Klein
Journal:  Can Med Assoc J       Date:  1982-09-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.